Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $891.36 billion, total revenue of $172.71 billion and a weighted average PE ratio of 49.27.
Market Cap
891.36B
Revenue
172.71B
Profits
18.09B
PE Ratio
49.27
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 243.30B | 0.93% | 1,580,678 | 46.34B |
| 2 | DHR | Danaher Corporation | 154.52B | 1.08% | 3,934,416 | 25.11B |
| 3 | NTRA | Natera, Inc. | 57.76B | 2.54% | 1,011,448 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 48.08B | 1.41% | 1,537,411 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 42.78B | 0.39% | 972,341 | 16.98B |
| 6 | WAT | Waters Corporation | 42.62B | 1.08% | 1,119,569 | 4.64B |
| 7 | ILMN | Illumina, Inc. | 42.00B | 5.14% | 1,895,817 | 4.49B |
| 8 | IDXX | IDEXX Laboratories, Inc. | 40.81B | 0.95% | 466,779 | 4.55B |
| 9 | MTD | Mettler-Toledo International Inc. | 31.06B | 1.34% | 180,649 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.49B | 0.07% | 775,460 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.32B | -0.65% | 607,866 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 22.47B | 1.15% | 1,520,098 | 1.18B |
| 13 | RVTY | Revvity, Inc. | 17.20B | 1.33% | 1,224,323 | 2.91B |
| 14 | MEDP | Medpace Holdings, Inc. | 17.08B | 1.55% | 159,767 | 2.78B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.41B | 1.27% | 679,856 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.67B | -0.20% | 745,643 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.38B | 1.91% | 1,255,476 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.28B | 6.01% | 774,112 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.58B | 3.96% | 507,438 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.15B | 1.29% | 1,595,051 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.63B | 2.81% | 325,044 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.23B | 1.53% | 1,525,259 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.64B | 3.74% | 966,612 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.29B | 2.36% | 897,071 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.10B | 2.06% | 1,385,286 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 2.01B | -0.59% | 405,115 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.71B | -0.37% | 1,835,905 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.70B | -0.19% | 558,760 | 35.41M |
| 29 | CSTL | Castle Biosciences, Inc. | 1.05B | 2.11% | 249,085 | 357.28M |
| 30 | OPK | OPKO Health, Inc. | 1.03B | 0.73% | 1,093,625 | 587.90M |
| 31 | FLGT | Fulgent Genetics, Inc. | 598.18M | 4.42% | 253,935 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 412.25M | 2.62% | 1,367,872 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 274.54M | 1.52% | 46,732 | 102.94M |
| 34 | XGN | Exagen Inc. | 203.98M | 3.06% | 251,154 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 163.36M | 1.91% | 7,699 | 73.70M |
| 36 | QUCY | Quantum Cyber N.V. | 113.49M | -2.88% | 637,103 | 537.08K |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 110.28M | 2.74% | 156,358 | 1.67M |
| 38 | MDXH | MDxHealth SA | 56.27M | 1.58% | 48,138 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 41.39M | -0.30% | 22,203 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 8.77M | -13.24% | 8,805 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 8.19M | -7.93% | 23,063 | - |
| 42 | XWEL | XWELL, Inc. | 7.06M | -10.60% | 110,222 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 6.06M | -16.22% | 657,428 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.85M | 3.67% | 72,019 | 466.30K |